AMPH Amphastar Pharmaceuticals Inc.
$28.60
Amphastar Pharmaceuticals Inc. (AMPH) Earnings News
Earnings press releases, previews and reviews for Amphastar Pharmaceuticals Inc. (AMPH), newest first. Our most recent is review: Amphastar Beats Handily on BAQSIMI Repair, but Margin Erosion and IMS Drag Temper the Record Quarter.
Thursday
November 5, 2026
9:13 PM ET
Amphastar Beats Handily on BAQSIMI Repair, but Margin Erosion and IMS Drag Temper the Record Quarter
Earnings Whispers · Review
Thursday
November 5, 2026
4:10 PM ET
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026
Thursday
October 29, 2026
12:08 PM ET
Amphastar's Rally Faces a Test as New Launches Race the IMS Warning Letter
Earnings Whispers · Preview
Thursday
October 29, 2026
6:00 AM ET
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026
Thursday
August 6, 2026
4:05 PM ET
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026
Wednesday
July 29, 2026
6:00 AM ET
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026